Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Yossef

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|March 7, 2017
Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher ActivityYonat Shemer-Avni, Kiran Kundu, Avishai Shemesh, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2011
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44Benyamin Rosental, Michael Brusilovsky, Uzi Hadad, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastomaVid Leko, Gal Cafri, Rami Yossef, et al.
Cancer Immunology Research|June 6, 2019
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNAKiran Kundu, Susmita Ghosh, Rhitajit Sarkar, et al.
Plos One|September 3, 2011
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talkShirin Elhaik-Goldman, Daniel Kafka, Rami Yossef, et al.
Plos One|January 27, 2011
Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assaysMeital Cohen, Rami Yossef, Tamir Erez, et al.
Nature Communications|January 27, 2019
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patientsGal Cafri, Rami Yossef, Anna Pasetto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Journal for Immunotherapy of Cancer|May 31, 2023
Cell surface marker-based capture of neoantigen-reactive CD8<sup>+</sup> T-cell receptors from metastatic tumor digestsPraveen D Chatani, Frank J Lowery, Neilesh B Parikh, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|March 7, 2017
Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher ActivityYonat Shemer-Avni, Kiran Kundu, Avishai Shemesh, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2011
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44Benyamin Rosental, Michael Brusilovsky, Uzi Hadad, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastomaVid Leko, Gal Cafri, Rami Yossef, et al.
Cancer Immunology Research|June 6, 2019
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNAKiran Kundu, Susmita Ghosh, Rhitajit Sarkar, et al.
Plos One|September 3, 2011
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talkShirin Elhaik-Goldman, Daniel Kafka, Rami Yossef, et al.
Plos One|January 27, 2011
Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assaysMeital Cohen, Rami Yossef, Tamir Erez, et al.
Nature Communications|January 27, 2019
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patientsGal Cafri, Rami Yossef, Anna Pasetto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Journal for Immunotherapy of Cancer|May 31, 2023
Cell surface marker-based capture of neoantigen-reactive CD8<sup>+</sup> T-cell receptors from metastatic tumor digestsPraveen D Chatani, Frank J Lowery, Neilesh B Parikh, et al.
Pageof 3